The arrival of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable excitement within the medical community. This groundbreaking dual GIP and GLP-1 agonist medication seems to offer impressive improvements in fat shedding compared to previous therapies. Early clinical studies have ind